Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,712.80
(
0.94%
)
Dow Jones
49,716.40
(
1.75%
)
Brent Oil
110.44
(
-1.73%
)
Bitcoin
76,357.57
(
0.77%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 176357

Thursday, 10/11/2018 4:22:56 PM

Thursday, October 11, 2018 4:22:56 PM

Post# of 257473
CORI acquired by private-equity firm for $12.50/sh—a 50% premium to today’s 4pm close:

https://finance.yahoo.com/news/corium-announces-agreement-gurnet-point-200300315.html

There’s also a $0.50 CVR contingent on FDA approval of Corplex Donepezil, a transdermal formulation of Aricept, for AD.

CORI IPOd 4.5 years ago at $8.00/sh (#msg-100011927), so the compound annual return from IPO to buyout was approximately 9%.

p.s. Chris Viehbacher, ex-CEO of SNY, is the managing partner of the private-equity firm in this transaction.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today